Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer

Head and Neck

Volumn 33, Issue 1, 2011, Pages 77-81

  Wang, Wen Lun ^a   Lee, Ching Tai ^a   Lee, Yi Chia ^b   Hwang, Tzer Zen ^a   Wang, Chih Chun ^a   Hwang, Jau Chung ^a   Tai, Chi Ming ^a   Chang, Chi Yang ^a   Tsai, Shang Shyue ^a   Wang, Cheng Ping ^b,c   Ko, Jenq Yuh ^b   Lin, Jaw Town ^a,b  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

esophageal cancers; head and neck cancers; image enhanced endoscopy; second primary tumors; synchronous

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL TRIAL; ENDOSCOPY; ESOPHAGEAL NEOPLASIA; ESOPHAGUS CANCER; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; CONFIDENCE INTERVALS; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, MULTIPLE PRIMARY; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TAIWAN;

EID: 78651359461     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21397     Document Type: Article

References (30)

1. Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon (France): IARC Press; 2000. p 270.
2. Taiwan Cancer Registry, Department of Health, Executive Yuan. 1972-2008. Cancer Registry Annual Report. Available at:.
3. Mariette C, Piessen G, Triboulet JP,. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8: 545-553.
4. Kleinberg L, Forastiere AA,. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007; 25: 4110-4117.
5. Nakamura K, Shioyama Y, Kawashima M, et al. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 1045-1050.
6. Natsugoe S, Matsumoto M, Okumura H, et al. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg 2005; 29: 46-49.
7. Slaughter DP, Southwick HW, Smejkal W,. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953; 6: 963-968.
8. Haughey BH, Gates GA, Arfken CL, Harvey J,. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992; 101 (2 Pt 1): 105-112.
9. Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S,. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 2002; 56: 517-521.
10. Lee CH, Lee JM, Wu DC, et al. Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer 2008; 122: 1347-1356.
11. Lee YC, Wang CP, Chen CC, et al. Transnasal endoscopy with narrow-band imaging and Lugol staining to screen patients with head and neck cancer whose condition limits oral intubation with standard endoscope (with video). Gastrointest Endosc 2009; 69 (3 Pt 1): 408-417.
12. Panosetti A, Luboinski B, Mamelle G, Richard JM,. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study. Laryngoscope 1989; 99: 1267-1273.
13. Larson JT, Adams GL, Fattah HA,. Survival statistics for multiple primaries in head and neck cancer. Otolaryngol Head Neck Surg 1990; 103: 14-24.
14. Franco EL, Kowalski LP, Kanda JL,. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. J Clin Epidemiol 1991; 44: 615-625.
15. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR,. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995; 75: 1343-1353.
16. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989; 17: 449-456.
17. McDonald S, Haie C, Rubin P, Nelson D, Divers LD,. Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment, and prevention. Int J Radiat Oncol Biol Phys 1989; 17: 457-465.
18. Leõn X, Quer M, Diez S, OrAús C, Lõpez-Pousa A, Burgués J,. Second neoplasm in patients with head and neck cancer. Head Neck 1999; 21: 204-210.
19. Leõn X, Ferlito A, Myer CM 3rd, et al. Second primary tumors in head and neck cancer patients. Acta Otolaryngol 2002; 122: 765-778.
20. Cohn AM, Peppard SB,. Multiple primary malignant tumors of the head and neck. Am J Otolaryngol 1980; 1: 411-417.
21. Fujita M, Rudoltz MS, Canady DJ, et al. Second malignant neoplasia in patients with T1 glottic cancer treated with radiation. Laryngoscope 1998; 108: 1853-1855.
22. Seitz HK, Stickel F,. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007; 7: 599-612.
23. Boyle P, Autier P, Bartelink H, et al. European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 2003; 14: 973-1005.
24. [No authors listed] Acetaldehyde. IARC Monogr Eval Carcinog Risk Chem Hum 1985; 36: 101-132.
25. Homann N, Kärkkäinen P, Koivisto T, Nosova T, Jokelainen K, Salaspuro M,. Effects of acetaldehyde on cell regeneration and differentiation of the upper gastrointestinal tract mucosa. J Natl Cancer Inst 1997; 89: 1692-1697.
26. Visapää JP, Götte K, Benesova M, et al. Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C1 allele, possibly due to salivary acetaldehyde. Gut 2004; 53: 871-876.
27. Muto M, Takahashi M, Ohtsu A, Ebihara S, Yoshida S, Esumi H,. Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region. Carcinogenesis 2005; 26: 1008-1012.
28. Yamamoto E, Shibuya H, Yoshimura R, Miura M,. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer 2002; 94: 2007-2014.
29. Wang CP, Lee YC, Yang TL, Lou PJ, Ko JY,. Application of unsedated transnasal esophagogastroduodenoscopy in the diagnosis of hypopharyngeal cancer. Head Neck 2009; 31: 153-157.
30. Wang CP, Lee YC, Lou PJ, et al. Unsedated transnasal esophagogastroduodenoscopy for the evaluation of dysphagia following treatment for previous primary head neck cancer. Oral Oncol 2009; 45: 615-620.